Results 31 to 40 of about 6,598 (209)
Frontiers in Pharmacology, 2021 Poziotinib is an orally active, irreversible, pan-HER tyrosine kinase inhibitor used to treat non-small cell lung cancer, breast cancer, and gastric cancer.
Jinhui Wang +10 more
doaj +1 more source
Metabolism of phenacetin in the rat
, 1984 The abuse of phenacetin-containing analgesic mixtures has been linked epidemiologically with nephrotoxicity and carcinogenicity in man. In addition, clinical and histopathological tests after chronic administration of phenacetin in man and animals have ...
D'Souza, Conrad Agnello (15931457)
core +1 more source
Personal Doses of Cocaine and Coca Paste are Adulterated in Cartagena de Indias (Colombia)
The Scientific World Journal, 2021 Knowledge of drug composition consumed on the streets and the identification and quantification of their adulterants is essential for understanding unexpected side effects, tracking routes, and drug profiling.
Jefferson Urzola-Ortega +2 more
doaj +1 more source
Insights into the Adsorption Performance of Emerging Contaminants on Granular Activated Carbon
Separations, 2023 Emerging contaminants are being detected at a high frequency, posing significant environmental and human health challenges. This study aimed to investigate the potential of using commercial granular activated carbon for adsorbing nine aqueous emerging ...
Sang-Hoon Lee, Namgyu Kim, Donghee Park
doaj +1 more source
The Colorimetric Determination of Phenacetin in Tablet Mixtures
, 1960 Phenacetin may be quantitatively converted to nitrophenetidine by nitration and subsequent saponification with sodium hydroxide. The nitrophenetidine thus formed is soluble in alkaline solution and may be determined colorimetrically at 445 mμ. The method
Lee Kum-Tatt, Chan Chian-Seng
core +1 more source
Effects of baicalin treatment on phenacetin pharmacokinetics.
, 2014 (A) The concentration-time profiles of phenacetin (5 mg/kg,i.v.) after treatment with normal saline (control) or baicalin (450 mg/kg, i.v.) in rats. (B) The changes in concentrations(%)-time profile of phenacetin (5 mg/kg, i.v.) after treatment with ...
Hai-ling Qiao (5658073) +6 more
core +1 more source
Case-control study on analgesics and nephropathy (SAN): protocol
BMC Nephrology, 2005 Background The association between intake of non-phenacetin-containing analgesics and the occurrence of chronic renal failure is still controversially discussed. A new epidemiologic study was planned and conducted in Germany and Austria.
van der Woude Fokko +4 more
doaj +1 more source
Pharmacokinetics of phenacetin in phenacetin abusers.
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1988 Although there are some reports which state that phenacetin is unlikely to be theprimary causative agent in analgesic nephropathy (Prescott, 1982), 80% of the 285phenacetin abusers observed in our clinic between 1962 and 1979 were suffering fromchronic interstitial nephritis (Nitzsche et al., 1980).
MINESHITA, Satoru +4 more
openaire +2 more sources